Table 8.
Effects of bacteria/inflammation on the property and function of GMSCs.
Inflammatory Factors | Effects | Refs |
---|---|---|
iGMSC vs normal GMSC | Similar phenotypes Increased osteogenic potentials |
Tomasello et al. (140) |
Similar phenotypes Decreased expression of Nanog, Oct3/4 and Sox-2 |
Soancă et al. (141) | |
Similar phenotypes Increased proliferation No difference in cell migration |
Al Bahrawy et al. (142) | |
Decreased expression of FasL and impaired immunomodulation on T cells in vitro Impaired therapeutic effects on mice colitis |
Yu et al. (59) | |
Reduced CFU & osteogenic potential Increased adipogenic potential |
Jauregui et al. (143) | |
Reduced osteogenic & adipogenic potentials Increased proliferation A pro-fibrotic phenotype Increased expression of inflammatory factors |
Li et al. (144) | |
TNF-α | Reduced viability Increased pro-inflammatory cytokines Impaired pro-angiogenic activity |
Giacomelli et al. (145) |
IL-1/TNF-α | Decreased CFU Reduced osteogenic potentials |
Zhang et al. (146) |
IL-1β/TNF-α/IFN-γ/Retinol | Enhanced characteristics Enhanced initial cellular proliferation Increase in the expression of the pluripotency markers Increase in the differentiation potential Activation of the intracellular Wnt/β‐catenin pathway |
Fawzy El-Sayed et al. (147) |
F. nucleatum | Promoting cell migration and chemokine/cytokine release Inhibiting the proliferation and osteogenic differentiation |
Kang et al. (148) |
Porphyromonas gingivalis-LPS | Increased proliferation Minimal inflammatory response No effects on CFU and osteogenic potentials |
Zhou et al. (149) |
Antibiotics/Oral Microbiota/LPS | Inhibition of proliferation, in vivo, mice | Su et al. (122) |